Bionic Eye Market Size - By Type (Implanted Eye, External Eye), By Technology (Mechanical, Electronic), By End Users (Ophthalmic Clinics, Hospitals, Others) and By Region: Global & Forecast, 2024-2033

  • 2023-12-01
  • 209
  • Healthcare & Life Sciences

Market Overview

Bionic Eye Market is projected to achieve a value of USD 386.23 Million in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 1,624.12 Million by 2033 with a CAGR of 13.4% during the forecast period 2024-2033.

An artificial visual aid intended to help those with visual impairments see again is called a bionic eye. Typically, it consists of an implant that stimulates the optic nerve or visual cortex to enable perception of these impulses as sight, a processor that transforms the captured images into electronic signals, and a camera. Bionic eyes are designed to improve the quality of life and partially restore vision for those who are visually impaired by avoiding damaged areas of the eye.

The increasing frequency of visual impairments worldwide and technological improvements are driving the bionic eye market's rapid expansion. The market is undergoing extensive research and development with the goal of improving visual prostheses, thanks to major manufacturers including Second Sight Medical Products, Pixium Vision, and Retina Implant AG. The aging population, growing healthcare expenditures, and the need for novel treatments for blindness or severe visual impairment are all contributing to the market's growth. Furthermore, partnerships between academic institutions and business entities advance the creation of increasingly advanced bionic eye technologies, which promote market expansion and accessibility for individuals requiring them.

The Argus II Retinal Prosthesis System manufactured by Second Sight Medical Products is one prominent example in the bionic eye market. This cutting-edge technology uses a pair of glasses with a built-in camera to take pictures and send them wirelessly to a retinal implant. Users with degenerative retinal disorders such as retinitis pigmentosa are able to discern patterns of light because the implant stimulates the remaining surviving cells in the retina. It dramatically enhances users' capacity to identify things and navigate their environment, even if it does not fully restore eyesight.

The COVID-19 epidemic has brought opportunities and challenges to the bionic eye market. First, the market encountered difficulties because to production hiccups, supply chain issues, and a drop in elective surgeries. Clinical investigations that were delayed and patient visits that were reduced were other variables that impacted research and development. However, throughout the epidemic, innovation and remote healthcare were brought to light. The swift advancement of technology gave rise to telemedicine applications designed to evaluate and counsel bionic eye users. Furthermore, post-pandemic market development may be fueled by the industry's attempts to close gaps in the market and increase accessibility to bionic eye technologies, as well as by increased healthcare spending and a tighter focus on healthcare solutions.

Market Scope

Report Attributes


Market Size in 2023

USD 386.23 Million

Market Forecast in 2033

USD 1,624.12 Million

CAGR % 2024-2033


Base Year


Historic Data


Forecast Period


Report USP

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Type, By Technology, By End Users and By Region

Growth Drivers

Ongoing advancements in medical technology, particularly in the fields of biotechnology and neurology, have paved the way for the development of sophisticated bionic eye implants. Improved materials, miniaturization, and enhanced surgical techniques contribute to the effectiveness and safety of bionic eye devices.

The increasing prevalence of vision impairments, including blindness, has driven the demand for innovative solutions like bionic eyes. As the global population ages, the incidence of age-related eye diseases such as macular degeneration and retinitis pigmentosa is on the rise, necessitating advanced vision restoration technologies.

Growing awareness of bionic eye technologies among patients and healthcare professionals is fostering greater acceptance. As understanding of the potential benefits of these devices increases, more individuals with vision impairments are likely to explore and adopt bionic eye solutions.

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

Key Companies

Nano Retina, Second Sight Medical Products, Inc., The Johns Hopkins University, Bionic Eye Technologies, Bionic Vision Australia, Optobionics Corporation, Biomedical Technologies Inc., Monash Vision Group, Retina Implant AG, Neostrata Company, Inc., MetaModal LLC, Pixium Vision. and Other.

Market Dynamics

Market Drivers

Increasing Prevalence of Vision Impairments

A key factor propelling the Bionic Eye market is the increasing incidence of vision impairments caused by diseases such as diabetic retinopathy, retinitis pigmentosa, and age-related macular degeneration. Efforts to find effective treatments increase when these disorders result in partial or total loss of vision. In order to address the urgent demand for better visual rehabilitation, bionic eye technology gives hope by striving to recover eyesight. In an effort to provide practical sight restoration choices for those with vision impairments, the market is expanding as a result of the growing demand for novel bionic eye technologies, which encourages more research, development, and investment in this area.

Rising Investments in Research and Development

The Bionic Eye market is driven forward in large part by the increase in investments made in research and development (R&D). Increasing financing directs resources toward improving surgical procedures, miniaturization, and gadget efficacy. These expenditures stimulate innovation, leading to the development of more sophisticated and affordable bionic eye technologies. R&D expenditures also help clinical studies, speeding up regulatory approvals and the commercialization process. Because of this, the market is seeing the introduction of innovative technologies that are pushing the envelope to provide better options for vision restoration, which in turn is increasing the accessibility and acceptance of bionic eye devices among the visually impaired population.

Market Restrains

Complexity of Surgical Procedures

A major barrier to the market's mainstream acceptance is the intricacy of the surgical procedures involved in bionic eye implantation. These complex surgeries come with higher expenses and possible dangers for patients since they require specific knowledge, tools, and careful post-operative care. Furthermore, the intrusive character of these operations, together with any possible discomfort or consequences, can discourage people from choosing bionic eye implants. The number of medical experts qualified to perform these surgeries is also constrained because to the technical complexities involved, which limits accessibility and slows adoption rates. These factors impede the market's expansion and wider acceptance of bionic eyes.

Market By Type Analysis

By Type, the Bionic Eye Market is Categories into Implanted Eye, External Eye. The External Eye segment accounts for the largest share of around 62% in 2022.

This market is expanding as a result of advancements in wearable technology, including smart glasses and external visual aids.

Market By Technology Analysis

By Technology, the Bionic Eye Market is Categories into Mechanical, Electronic. The Electronic segment accounts for the largest share of around 72% in 2022.

Electronic components are used in electronic bionic eyes, which are based on microelectrode array technology, to either directly interact with the visual cortex or stimulate the remaining healthy retinal cells. The capacity to give consumers artificial but useful vision is what distinguishes these technologies. Improving electrode designs and creating more compact, implantable devices that provide improved visual acuity and more compatibility with the user's visual cortex are the current trends in electronic bionic eyes.

Market By End Users Analysis

By End Users, the Bionic Eye Market is Categories into Ophthalmic Clinics, Hospitals, Others. The Hospitals segment accounts for the largest share of around 41% in 2022.

Hospitals play a crucial role in the implantation and post-operative care of patients who get bionic eyes, making them important end users in the bionic eye industry. Modern, technologically advanced surgical units are available in these medical centers.

Market Regional Analysis

North America dominate the Bionic Eye Market with the highest revenue generating market with share of more than 42%. The North American market is driven by the dominance of major players in the industry, such as Second Sight and Second Sight Medical Products. These companies spend a lot of money on research and development, which is why more advanced bionic eye technologies are being created. The increasing prevalence of eye disorders including retinitis pigmentosa and macular degeneration has led to a significant demand for bionic eyes.

Europe is the second-biggest market for Bionic Eye globally, accounting for about 30% of the market. The high incidence of eye conditions and the growing government support for R&D are the main factors driving the European market.

Asia Pacific is expected to be the fastest-growing market for Bionic Eye during the forecast period. The Asia Pacific market is expected to develop at the fastest rate due to the region's aging population and the rise in eye ailments. According to World Health Organization predictions, there would be 777 million persons over 65 in the Asia Pacific region by 2050. With an aging population, there will likely be a greater need for bionic eyes. Additionally, eye diseases are very common in the Asia-Pacific region.

Competitive Analysis

The Bionic Eye Market is dominated by a few large companies, such as Nano Retina, Second Sight Medical Products, Inc., The Johns Hopkins University, Bionic Eye Technologies, Bionic Vision Australia, Optobionics Corporation, Biomedical Technologies Inc., Monash Vision Group, Retina Implant AG, Neostrata Company, Inc., MetaModal LLC, Pixium Vision. and Other.

There are some of the key trends that are shaping the competitive landscape of the Bionic Eye Market.

2022, The Prima System, a bionic eye implant created by French company Pixium Vision, was given to a patient in the Netherlands. For those suffering from geographic atrophy (GA), the most common type of dry age-related macular degeneration (AMD), this implant may provide some hope for a partial restoration of vision.

2022, As part of the PRIMAvera pivotal trial, Pixium Vision SA, a bioelectronics business specializing in bionic vision systems, successfully completed the first patient implantation in the Netherlands. This significant event comes after the Rotterdam Eye Hospital was chosen as the first PRIMAvera clinical site and the Dutch Ministry of Health, Welfare, and Sport approved the PRIMAvera study.

Research Report Following Segments:

By Type

·         Implanted Eye

·         External Eye

By Technology

·         Mechanical

·         Electronic

By End Users

·         Ophthalmic Clinics

·         Hospitals

·         Others

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Bionic Eye Market in 2022?

Bionic Eye Market was valued at USD 311.4 Million in 2022.

What is the growth rate for the Bionic Eye Market?

Bionic Eye Market size will increase at approximate CAGR of 13.4% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Bionic Eye Market are Nano Retina, Second Sight Medical Products, Inc., The Johns Hopkins University, Bionic Eye Technologies, Bionic Vision Australia, Optobionics Corporation, Biomedical Technologies Inc., Monash Vision Group, Retina Implant AG, Neostrata Company, Inc., MetaModal LLC, Pixium Vision. and Other.

Which region dominates the Bionic Eye Market?

North America dominates the market with an active share of 42%.


Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI